Reply to Akenroye and Keet
- PMID: 38949602
- PMCID: PMC11284317
- DOI: 10.1513/AnnalsATS.202404-424LE
Reply to Akenroye and Keet
References
-
- Kearney CM, Sangani R, Shankar D, O’Connor GT, Law AC, Walkey AJ, et al. Comparative effectiveness of mepolizumab, benralizumab, and dupilumab among patients with difficult-to-control asthma: a multicenter retrospective propensity-matched analysis. Ann Am Thorac Soc . 2024;21:866–874. - PMC - PubMed
-
- Brusselle GG, Koppelman GH. Biologic therapies for severe asthma. N Engl J Med . 2022;386:157–171. - PubMed
Publication types
LinkOut - more resources
Full Text Sources